Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-2,953 Cr₹10,233 Cr₹5.27 Cr₹-740 Cr₹605 Cr

What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Financing Activities ratio of MANKIND PHARMA is ₹-2,953 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-2,953 Cr
Mar2025₹10,233 Cr
Mar2024₹5.27 Cr
Mar2023₹-740 Cr
Mar2022₹605 Cr

How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-2,953 Cr
Negative
Mar2025 ₹10,233 Cr
194,066.22
Mar2024 ₹5.27 Cr
Positive
Mar2023 ₹-740 Cr
Negative
Mar2022 ₹605 Cr -

Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,963.6 Cr -1.2% -7.2% -3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr 1% -2.7% 15.7% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 0.7% 17.1% 40.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr -0.3% -3.7% 37.9% Stock Analytics
CIPLA ₹115,216.0 Cr -0.3% 2.3% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.4% 0.7% -6.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.2%

-7.2%

-3.5%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses